Edit concept Question Editor Create issue ticket

Renal Tubular Acidosis

Renal tubular acidosis (RTA) is a pathological condition in which a increased quantity of acid can be seen in plasma due to the failure of kidneys to acidify urine in a proper manner [1].


Presentation

In general RTA is asymptomatic, but it might involve some bone dysfunctions such as bone pain, osteomalacia in adults and rickets in children due to the marked levels of demineralization, which is particularly frequent in Type 1 and Type 2 RTA. In these types bone involvement is frequently combined with nephrolithiasis and nephrocalcinosis.

The signs and symptoms of hypokalemia, such as muscle weakening, hyporeflexia, and paralysis, are evident, especially in the already mentioned Type 1 and Type 2 RTA. These can sometime be combined with severe electrolyte disturbances, although these are very rare. Type 4 RTA too is usually asymptomatic, apart from a mild acidosis, but if hyperkalemia is severe cardiac arrhythmias or paralysis might become clearly pronounced. Type 2 RTA might also present with signs of extracellular fluid volume depletion due to urinary water loss and marked electrolyte excretion.

Lymphadenopathy
  • She had multiple lymphadenopathies. There were 20% eosinophil in blood smear and 32% in bone marrow aspiration.[ncbi.nlm.nih.gov]
Polydipsia
  • Clinical Manifestations In children the clinical spectrum is nonspecific including anorexia, failure to thrive, vomiting and dehydration, constipation, polyuria, and polydipsia.[renaltube.com]
  • Patients with dRTA can be asymptomatic or can present with polyuria, polydipsia, weakness and fatigue (symptoms associated with hypokalemia).[orpha.net]
  • ., lead, cadmium , mercury ) Clinical features Vitamin D -resistant rickets / osteomalacia Stunted growth Polyuria polydipsia , dehydration In some cases, features of hypokalemia (e.g., muscle weakness, hyporeflexia, paralysis, U waves and flattened T[amboss.com]
  • Children with proximal RTA may have symptoms related to untreated hypokalemia including polyuria, polydipsia, constipation, anorexia, vomiting, and muscle weakness. Distal RTA (Type 1) Rathophysio/ogy.[healio.com]
Bone Pain
  • […] by multiple myeloma , heavy metal poisoning, or certain drugs Inability to reabsorb bicarbonate from the urine, so too much bicarbonate is excreted High blood acidity Fragile bones Bone pain Mild dehydration Low potassium levels in the blood Decreased[merckmanuals.com]
  • This condition could lead to hypokalemic paralysis, where an individual experiences extreme muscle weakness Aberrant heart rhythms Permanent hearing loss Fatigue, difficulty in movement due to bone pain Nephrocalcinosis, or calcium deposits in kidneys[dovemed.com]
  • This bone disorder is characterized by bone pain, bowed legs, and difficulty walking.[medicalneed.com]
  • Other symptoms of RTA you might notice include: confusion, decreased alertness, or fatigue increased breathing and heart rates decreased urination muscle weakness muscle cramps and pain in the back and abdomen rickets (a disorder that can cause bone pain[connecticutchildrens.org]
Skeletal Dysplasia
  • Favus, Genetic Diagnosis of Skeletal Dysplasias, Genetic Diagnosis of Endocrine Disorders, 10.1016/B978-0-12-800892-8.00012-9, (173-189), (2016). Thierry O. Wambo, Liao Y. Chen, Stanton F. McHardy and Andrew T.[doi.org]
Psychiatric Symptoms
  • Subsequently, her psychiatric symptoms and biochemical findings improved. Recognition of drug-induced psychotic symptoms and renal tubular acidosis is important during concomitant topiramate therapy in psychiatric clinic.[ncbi.nlm.nih.gov]
Polyuria
  • Despite polyuria, both patients developed resistant hyperkalemia that needed further hemodialysis. The urinary pH, arterial pH, delta ratio, and transtubular potassium gradient confirmed RTA4.[ncbi.nlm.nih.gov]
  • Clinical Manifestations In children the clinical spectrum is nonspecific including anorexia, failure to thrive, vomiting and dehydration, constipation, polyuria, and polydipsia.[renaltube.com]
  • Patients with dRTA can be asymptomatic or can present with polyuria, polydipsia, weakness and fatigue (symptoms associated with hypokalemia).[orpha.net]
  • Clinical features otherwise depend on the type of renal tubular acidosis: type 1: hypercalciuria, polyuria, impaired growth, nephrocalcinosis , urolithiasis and hypokalemia 2 type 2: rickets and osteomalacia are not usually seen unless hypophosphatemia[radiopaedia.org]

Workup

In adults the diagnosis of RTA is largely based on the observation of unexplained and incidental laboratory findings regarding blood, electrolyte concentrations and acid-base parameters, while in children it is mainly based on growth retardation, rickets, and failure to thrive.

Studying the clinical history might be useful, as many metabolic diseases, such as diabetes mellitus and adrenal insufficiency, can substantially increase the predisposition to RTA. The study of the patient’s clinical history should also include past exposure to certain drugs and toxins, which as previously seen might damage the nephron tubule both in the distal and the proximal region. The harmful drugs include carbonic anhydrase inhibitors, amphotericin-B, and ibuprofen, while RTA-inducing toxins include heavy metals and cis-platinum.

Laboratory evaluation of blood, urine acid-base parameters and electrolyte concentrations can be performed with routine procedures regularly used in clinical settings. Usually, low plasma bicarbonate concentrations is observed in both acidosis and respiratory alkalosis. Therefore, differentiation between these two disorders in paramount. In this regard, observing elevated pH levels might be very useful, as it can cause low plasma bicarbonate levels in the cases of respiratory alkalosis. The plasma anion gap is normal in all type of RTA, therefore increased levels of this parameter should suggest the presence of another type of acidosis [20] [21]. In general, decreased plasma bicarbonate levels, hyperchloremia, acidemia, and a normal serum anion gap should support the diagnosis of RTA.

Urine analysis should show impaired urinary acidification and failed bicarbonate reabsorption, while plasma bicarbonate should be low and coupled with hyperchloremia. Aldosterone deficiency or resistance can be indicated by hyperkalemia in the cases of distal RTA.

Furthermore, radiologic findings can be useful for the diagnosis of RTA. Abdominal X-ray or abdominal CT scan can detect nephrocalcinosis and the presence of stones in the kidneys in the cases of classic distal RTA. Evaluation of urinary tract obstruction, instead, can be performed with ultrasound, nuclear renal scan, or spiral CT scan in the case of hyperkalemic distal RTA.

Nephrolithiasis
  • Nephrolithiasis, which may occur in any of the subsets of type I renal tubular acidosis, accounts for most of the morbidity in adults and adolescents. Major risk factors for nephrolithiasis include alkaline urine, hypercalciuria and hypocitraturia.[ncbi.nlm.nih.gov]
  • This is the first demonstration of renal acidification defects and nephrolithiasis in heterozygous carriers of a mutant B1 subunit that cannot be attributable to negative dominance.[ncbi.nlm.nih.gov]
  • She had recurrent nephrolithiasis and had operated because of hydronephrosis. She had two episodes of fatigue and walking disability previously. Hyperchloremic metabolic acidosis with normal anion gap determined in blood gas analyze.[ncbi.nlm.nih.gov]
  • The most important consequence of dRTA is (recurrent) nephrolithiasis. The diagnosis is based on a urinary acidification test. Potassium citrate is the treatment of choice.[ncbi.nlm.nih.gov]
Glycosuria
  • He was also found to have hyperchloraemic metabolic acidosis with hypokalaemia, hypophosphataemia, phosphaturia and glycosuria, which favoured a diagnosis of proximal renal tubular acidosis.[ncbi.nlm.nih.gov]
  • The blood salicylate level was undetectable, and a urinalysis showed glycosuria, proteinuria and elevated beta-2 microglobulin and n-acetyl glucosamine levels, with a normal urinary pH despite the acidosis.[ncbi.nlm.nih.gov]
  • Urinalysis showed inappropriate alkaline urine (urinary PH: 7), glycosuria with normal blood glucose, phosphaturia and uricosuria. These values indicated the presence of both distal and proximal RTA.[ncbi.nlm.nih.gov]
  • […] less than 5.3. pRTA also has several causes, and may occasionally be present as a solitary defect, but is usually associated with a more generalized dysfunction of the proximal tubular cells called Fanconi syndrome, in which there is also phosphaturia, glycosuria[en.wikipedia.org]
  • Patients with this generalized abnormality, the Fanconi syndrome, usually have glycosuria, aminoaciduria, citraturia, and phosphaturia.[ommbid.mhmedical.com]
Hyponatremia
  • It is associated with increased renin activity, hyponatremia, hyperkalemia and volume depletion.[netscut.templaro.com]
  • Non-SIG Acidosis (Drip or IV Fluid) SIG Acidosis (As an IV Fluid) Increased ICP (Drip) Hyperkalemia (As an IV Fluid) Hyponatremia (Drip) ICP NaBicarb can be used as a substitute for hypertonic saline in increased ICP (Neurocrit Care 2010;13:24 & Neurocrit[emcrit.org]
  • Type I pseudohypoaldosteronism involves a defect at the aldosterone receptor level and is associated with salt wasting, volume depletion, and hyponatremia.1 Plasma renin and aldosterone levels are increased.[healio.com]
Abnormal Renal Function
  • Admission blood tests demonstrated abnormal renal function with a urea of 22 mmol/l (normal: 2.5–7.0 mmol/l) and creatinine of 176 µmol/l (normal: 60–110 µmol/l). Serum potassium was reduced at 2.9 mmol/l (normal: 3.6–5.0 mmol/l).[academic.oup.com]

Treatment

The first goal of the treatment of RTA is to restore blood pH and bicarbonate levels, which can be done by giving the patient daily doses of sodium-bicarbonate or a solution of sodium citrate and citric acid (Shohl solution).

In Type 1 (distal) RTA alkali replacement therapy is performed to correct metabolic acidosis and maintain plasma potassium levels, so than consumption of skeleton and muscle mass can be prevented. Potassium deficits might be significant, but its administration should be controlled to avoid adverse side effects. If necessary, potassium supplements can be provided.

In Type 2 (proximal) RTA patients usually need higher doses of alkali which can be provided by adjusting the Shohl solution concentration accordingly. Also in this case, potassium supplements might be provided if necessary. It should be noted that as more alkali is given and bicarbonaturia increases, urinary potassium loss is exacerbated. In this case, to generate a mild volume depletion and increase proximal reabsorption, hydrochlorothiazide can be given to patients. However, this drug might worsen potassium loss, thus potassium supplementation is highly advised also in this case.

Replacement of bicarbonate loss is paramount in Fanconi syndrome, which can be done by following the same treatment for Type 2 RTA. Phosphate supplementation and vitamin D are required, while amino acids loss can be addressed by following an appropriate diet. The description of the treatments for the other metabolic disorders usually associated with Fanconi syndrome goes beyond the purposes of this discussion.

The major issues in Type IV RTA are acidosis and hyperkalemia, which in this condition might be severe. Correction of potassium overload might cause acidosis to increase significantly, due to increased ammonia production and excretion. Therefore, the doctor and patient should pay particular attention to avoid drugs associated with hyperkalemia and salt substitutes containing potassium. When Type 4 RTA is caused by aldosterone deficiency, fludrocortisones might be provided as replacement, while dietary potassium restriction is effective when hyperkalemic distal RTA is the result of inappropriate response to aldosterone. In these cases patients do not respond to fludrocortisone, which should be replaced by furosemide or other loop diuretics. Patients can received Shohl solution, while K-Shohl solution and other forms of citric acid preparations should be avoided.

Prognosis

The prognosis is good, especially in terms of prevention of renal stone formation and amelioration of nephrocalcinosis in the cases of distal RTA. If treatment is started early, it can even restore growth in children with severe proximal RTA, serum potassium can be controlled and acidosis ameliorated in the cases of hyperkalemic distal RTA, even though the long-term outcomes of treatment are still unknown.

The prognosis for Fanconi syndrome depends on the clinical case considered. If the disorder is due to inherited metabolic diseases, prognosis might not be good, and patients might fail to recover. The situation is different when it comes to cases of RTA due to drugs or toxin exposure, where the Fanconi syndrome resolves once the kidneys heal from the injury and recovery can occur once the toxin is removed and further exposure is avoided.

By contrast, in the cases of proteinuria-associated diseases the prognosis largely depends on the treatment of the primary disorder, which is really responsible for the kidney dysfunction, and recovery is only possible when this primary disorder is under control.

Etiology

The etiology of RTA includes a variety of many factors which can be either genetic and acquired in nature. The genetic etiological factors involve mutations in the genes of those proteins with key role in the renal function. For instance, one of the most important of these genetic factors is represented by the mutations that occur in the gene decoding proton pump and anion exchanger, responsible for removing bicarbonates from the tubule [2] [3] [4] [5] [6], or on the gene decoding the sodium bicarbonate cotransporter [7] [8] [9]. The acquired factors include episodes of interstitial inflammation and injury [10] [11], responsible for tubule cell injury and loss of proton pumps [12]  [13], or aldosterone deficiency [14] [15]. RTA might also be triggered by the use of many drugs, such as amphotericin B, toluene, and nonsteroidal anti-inflammatory drugs (NSAIDs).

Particularly frequent as etiological factor is also Fanconi syndrome, a disease of the proximal renal tubules in which glucose, amino acids, uric acid, phosphate and bicarbonate are lost in great quantity into the urine instead of being reabsorbed. The syndrome affects the proximal tubule and might have genetic origins, even though it is frequently associated to the use of certain drugs or the ingestion of heavy metal.

Epidemiology

The prevalence and incidence of RTA are not exactly known as the disorder is often not recognized and its frequency underestimated. However, inherited forms of RTA appear to be much rarer then acquired ones [7] [16] such as those due to renal failure. In the US, the most common forms of RTA are hyperkalemic distal RTA in urinary tract obstruction and hyperkalemic distal RTA secondary to aldosterone deficiency in diabetes.

Fanconi syndrome is very rare as primary cause of RTA, while metal exposure varies significantly according to the location, residence, occupation and in general the social status of the people affected. The incidence of RTA induced by drugs has been constantly increasing over the last years, perhaps due to the unclear side effects or the not always well-defined pharmacological interaction among these medications.

Sex distribution
Age distribution

Pathophysiology

The pathophysiology of RTA varies according to the type and its etiological factor. There are four type of RTA: Type 1 (distal) RTA, Type 2 (proximal) RTA, Type 3 RTA, and Type 4 RTA.

  • Type 1 (distal) RTA: This is the first described form of RTA. It is caused by the failure of the alpha intercalated cells of the medullary collecting duct in the distal region of the nephron to secret H+ into the lumen of the duct itself. The failed elimination of H+ causes acidemia in the body, which is combined with hypokalemia due to an inadequate re-absorption of K+ [1]. The proton retention and potassium excretion result in urine stone formation, which is a typical characteristic of this type of RTA not seen in the others, as well as bone demineralization due to this mineral loss. There can be several reasons for the failure of alpha intercalated cells.
  • Type 2 (proximal) RTA: In this case the failure interests the proximal tubule of the nephron, where the tubular cells fail to reabsorb filtered bicarbonate from the urine. Because of the proximal position of the problem, this type of RTA does not severely limit the level of urine acidification, which can be lower than 5.3, even though bicarbonate wasting and in general acidemia remain substantial. This form is generally associated with the already mentioned Fanconi syndrome, as general pathological condition affecting the proximal tubule of the nephron due to the inability of reabsorbing several compounds of primary physiological importance. This in turn causes phosphaturia, uricosuria, aminoaciduria, and tubular proteinuria that result in a marked bone demineralization.
  • Type 3 RTA (combined proximal and distal RTA): This form of RTA is a combination of Type 1 and Type 2, rarely seen in infants and children. It is mainly due to mutations on the gene of carbonic anhydrase II, an enzyme responsible for the rapid interconversion of carbon dioxide and water into bicarbonate and protons, resulting not only in RTA but also in osteoporosis, cerebral calcification, and mental retardation [17] [18] [19].
  • Type 4 RTA: Rather than a form of RTA, Type 4 is more a consequence of hypoaldosteroism, a phatological condition characterized by decreased plasma levels of aldosterone, resulting in a physiological reduction of proximal tubular ammonium excretion and decreased urine buffering capacity. Sometime type 4 RTA can be caused by pseudohypoaldosteronism, a condition mimicking hypoaldosteroism as it is caused by the failure to respond aldosterone rather than the decreased plasma levels of this hormone, or by some drugs like non-steroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors or Angiotensin II receptor blockers (ARBs). The main feature of this type is hyperkalemia, while the levels of urine acidification remain normal

Prevention

Patients are recommended to take alkali on a daily basis. Mixed solution of cold water or lemonade with sweeteners might be a very effective prevention measure, together with a strict avoidance of potassium foods and drugs causing hyperkalemia. As RTA is a lifelong issue, prevention measures should always be followed by patients through prevention programs previously planed with the doctor.

Summary

The cause of renal tubular acidosis (RTA) lays in a dysfunction of the kidneys. In normal conditions, blood is filtered in the kidneys through the action of their functional unit known as nephron. The filtrate produced by this system passes through a long tubule where it is progressively processed, allowing the exchange of salts and other important biological compounds which then drain into the bladder to be expelled as urine. Such system is pivotal for maintaining the biochemical balance of blood plasma, that has to be continuously kept within the appropriate physiological ranges.

RTA occurs when this system fails to recover a sufficient quantity of bicarbonates from the filtrate and to secrete the appropriate quantity of hydrogen ions into the urine, in other words an insufficient urinary acidification without urea and anion retention. This condition is an example of metabolic acidosis, a term which indicates a decrease of the plasma pH. Episodes of metabolic acidosis might also be triggered by renal insufficiency, but it is only in RTA that can develop in physiologically-functioning kidneys.

Patient Information

Renal tubular acidosis (RTA) is a pathological condition in which a increased quantity of acid can be seen in plasma due to the failure of kidneys to acidify urine in a proper manner. The consequence of this condition is an impaired balance of major plasma physiological parameters, such as pH, bicarbonate levels and amino acids concentration, which result in the main features of RTA, like acidemia, hypokalemia or bone demineralization. There are four types of renal tubular acidosis.

Patients are recommended to take alkali on a daily basis. Mixed solution of cold water or lemonade with sweeteners might be a very effective prevention measure, together with a strict avoidance of potassium foods and drugs causing hyperkalemia. As RTA is a lifelong issue, prevention measures should always be followed.

References

Article

  1. Laing CM, Toye AM, Capasso G, Unwin RJ. Renal tubular acidosis: developments in our understanding of the molecular basis. Int. J. Biochem. Cell Biol. 2005 37 (6): 1151–61.
  2. Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol. 2002;13:2178-2184.
  3. Karet FE, Finberg KE, Nelson RD, et al: Mutations in the gene encoding the B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet. 1999;21:84-90.
  4. Karet FE, Gainza FJ, Gyory AZ, et al: Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A. 1998;14:6337-6342.
  5. 5. Bruce LJ, Cope DL, Jones GK, et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest. 1997;100:1693-1707.
  6. Smith AN, Skaug J, Choate KA, et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet. 2000;26:71-75.
  7. Igarashi T, Sekine T, Inatomi J, et al. Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol. 2002;13:2171-2177.
  8. Igarashi T, Inatomi J, Sekine T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet. 1999;23:264-266.
  9. Bernarado AA, Bernardo CM, Espiritu DJ, et al. The sodium bicarbonate cotransporter: structure, function, and regulation. Semin Nephrol. 2006;26:352-360.
  10. Batlle D, Moorthi KM, Schluter W, et al. Distal renal tubular acidosis and the potassium enigma. Semin Nephrol. 2006;26:471-478. 
  11. Rodriguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160-2170.
  12. Cohen EP, Bastani B, Cohen MR, et al. Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992;3:264-271. 
  13. DeFranco PE, Haragasim L, Schmitz PG, et al. Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sjogren's syndrome. J Am Soc Nephrol. 1995;6:295-301.
  14. DeFronzo, RA. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 1980;17:118-134. 
  15. Batlle DC. Hyperkalemic hyperchloremic metabolic acidosis associated with selective aldosterone deficiency and distal renal tubular acidosis. Semin Nephrol. 1981;1:260-273.
  16. Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol. 2002;13:2178-2184.
  17. Sly WS, Whyte MP, Sundaram V et al.. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N. Engl. J. Med. 1985 313 (3): 139–45.
  18. Shah GN, Bonapace G, Hu PY, Strisciuglio P, Sly WS. Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation. Hum. Mutat. 2004 24 (3): 272.
  19. Pushkin A, Abuladze N, Gross E et al. Molecular mechanism of kNBC1-carbonic anhydrase II interaction in proximal tubule cells. J. Physiol. 2004 (Lond.) 559 (Pt 1): 55–65.
  20. Emmett M, Narins RG. Clinical use of the anion gap. Medicine (Baltimore). 1977;56:38-54.
  21.  Oh MS, Carroll HJ. Value and determinants of urine anion gap. Nephron. 2002;90:252-255.

Ask Question

5000 Characters left Format the text using: # Heading, **bold**, _italic_. HTML code is not allowed.
By publishing this question you agree to the TOS and Privacy policy.
• Use a precise title for your question.
• Ask a specific question and provide age, sex, symptoms, type and duration of treatment.
• Respect your own and other people's privacy, never post full names or contact information.
• Inappropriate questions will be deleted.
• In urgent cases contact a physician, visit a hospital or call an emergency service!
Last updated: 2018-06-22 00:11